Informative Report On (COVID-19 Updates) mHealth Market To See Record Break Revenue $230 billion By 2027

The demand form Health is on a rise, owing to surge in incidence of chronic diseases such as diabetes and cancer. Furthermore, rise in awareness related to use of mHealth across the globe is another factor that fuels the growth of the market.

The global mHealth market was valued at $46 billion in 2019, and is expected to reach $230 billion by 2027, registering a CAGR of 22.3% from 2020 to 2027.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/77

COVID-19 scenario-

1) The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.

2) The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.

3)However, as the world has been recovering from the pandemic, the market is estimated to get back on track.

Mobile health provides health service and information through mobile communication devices to address the health priorities and concerns. The advanced mobile and wireless technologies have transformed the face of healthcare services across the globe and are rendering the growth of mHealth market. Moreover, the continued growth in coverage of mobile cellular networks, rapid advances in mobile technologies & applications, increasing lifestyle diseases and growing awareness among patient population in emerging economies, are some of the key factors fostering the growth of mHealth market. On contrary, the lower accuracy of the devices, technology's infancy in middle and lower income economies, weak reimbursement coverage, uncertainty in government regulations in certain regions, and low adoption among ageing population is hampering the market growth to a certain extent.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/77

The major chunk of mHealth devices market - i.e. ~71% - is collectively commanded by BP monitors, blood glucose monitors and cardiac monitors. The largest share of these monitors can be attributed to increased affordability of mobile compatible devices, integration of innovative technologies in monitoring devices and the increasing lifestyle disease such as diabetes, stroke, COPD, ischemic heart to name a few. Within mHealth services, diagnostic, monitoring and treatment services collectively hold about 74% of the market. The rapid growth of mHealth services market is attributed to rising government initiatives, increasing mHealth awareness programs in underdeveloped regions etc.

Geographically, North America and Europe constitute the two largest markets for mHealth and collectively accounted for 67% of the market revenue in 2014. They are expected to continue its hold on the global market throughout the forecast period. Early adoption of innovative technology, large patient population and high capacity to pay for services are some of the key factors responsible for the growth of mHealth market in these regions. However, the market outlook across developing economies is looking favorable and strong owing to the increasing awareness of chronic diseases, favorable government regulations and increased healthcare expenditure. Philips healthcare, Bayer Healthcare and Sanofi are some of the key companies enjoying a strong foothold in mHealth market, especially in Asian countries.

Access Full Report @ https://www.alliedmarketresearch.com/mobile-health-market

The Major Key players profiled Are:

Bayer Healthcare., Boston Scientific Corporation, Dexcom, Inc., Johnson & Johnson, Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, Omron Corporation, Samsung Group, and Sanofi.

Key Findings Of The Study:

• By type, the mHealth services segment occupied approximatelytwo-thirds share of the global mHealth market in 2019.
• By application, the cardiovascular diseasessegment occupied approximately half of the global mHealth market share in 2019.
• By application, the neurological diseasessegment is anticipated to grow with the highest CAGR throughout the forecast period.
• By stakeholders, the healthcare providers segment is anticipated to grow with the highest CAGR throughout the mHealth marketforecast period.
• By region, Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by Middle East.

Similar Reports:

Antidepressant Drugs Market : https://www.einnews.com/pr_news/527197341/antidepressant-drugs-market-is-generating-revenue-of-15-98-billion-by-2023-at-cagr-2-1-growth-rate

Dental Implants and Prosthetics Market : https://www.einnews.com/pr_news/527457106/dental-implants-and-prosthetics-market-growing-at-a-cagr-of-8-8-and-to-target-12-74-billion-by-2023

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.